(Q45943150)

18 December 2017

title

Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group. (English)

1 reference

18 December 2017

author name string

S Roy

1

1 reference

18 December 2017

W Koltun

2

1 reference

18 December 2017

A Chatwani

3

1 reference

18 December 2017

M G Martens

4

1 reference

18 December 2017

R Dittrich

5

1 reference

18 December 2017

D R Luke

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

18 December 2017

The American Journal of Surgery

published in

1 reference

18 December 2017

volume

176

1 reference

18 December 2017

issue

6A Suppl

1 reference

18 December 2017

page(s)

67S-73S

1 reference

18 December 2017

Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Patient costs for prophylaxis and treatment of obstetric and gynecologic surgical infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

In vitro activity of the new fluoroquinolone CP-99,219.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

In-vitro activity of trovafloxacin (CP99,219) tested by two methods against 150 vancomycin-resistant enterococcal isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Technique for calculation of the true costs of antibiotic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Evaluation of new anti-infective drugs for the treatment of acute pelvic infections in hospitalized women. Infectious Diseases Society of America and the Food and Drug Administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Multicenter comparison of cefotetan and cefoxitin in the treatment of acute obstetric and gynecologic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Recent advances in antibiotic regimens for the treatment of obstetric-gynecologic infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Effect of Maalox and omeprazole on the bioavailability of trovafloxacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2898%2900223-2

10.1016/S0002-9610(98)00223-2

7 January 2021

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017